Navigation Links
ADVENTRX Receives Refuse to File Letter from FDA on ANX-530 New Drug Application
Date:3/1/2010

and uncertainties include, but are not limited to: FDA's requirements for the ANX-530 NDA to be accepted for review do not justify continued development of ANX-530; ADVENTRX's dependence on the success of ANX-530, and increased uncertainty as to whether ANX-530 will receive regulatory approval or be commercialized successfully; the potential that FDA may not accept a resubmitted ANX-530 NDA for review, or that the bioequivalence data and other information included in the ANX-530 NDA may not adequately support bioequivalence with Navelbine, including as a result of performing pharmacokinetic equivalence analyses based on a patient population other than the population on which ADVENTRX based its analysis; the potential that changes made in transferring the manufacturing process for ANX-530 may result in a lack of comparability between the commercial product and the material used in clinical trials, and that FDA may require ADVENTRX to perform additional non-clinical or clinical studies; the potential for FDA to impose other requirements to be completed before or after approval of the ANX-530 NDA; ADVENTRX's reliance on third parties to assist with its bioequivalence trials, regulatory submissions, manufacturing and other important aspects of the ANX-530 development program, and the risk that FDA approval may be delayed if their performance is found to have been substandard; the possibility that patent claims covering ANX-530 will not issue or, if they do, that such claims, which likely will be limited to a specific intravenous emulsion formulation of vinorelbine, will not be sufficient to preclude development of other formulations of vinorelbine by competitors; the risk of investigator bias in reporting adverse events as a result of the open-label nature of the ANX-530 bioequivalence study, including bias that increased the reporting of adverse events associated with Navelbine and/or that decreased the reporting of adverse events associated with ANX-530; the risk that
'/>"/>
SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ADVENTRX Announces Management Promotions
2. ADVENTRX Appoints Icahn Representative to Board of Directors
3. ADVENTRX Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference on February 9
4. ADVENTRX Pharmaceuticals to Present at the Lippert/Heilshorn Life Sciences Virtual Conference
5. ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514
6. ADVENTRX Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26
7. ADVENTRX Pharmaceuticals Announces Closing of Financing
8. ADVENTRX Announces Results From ANX-514 Bioequivalence Study
9. ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study
10. ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)
11. ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/tzzq39/investigation ) has ... China,s Trastuzumab Market, 2010-2019" report to their offering. ... FDA to be used in the clinic in September ... product of Roche. In 2013, the sales value of ... After entering China in 2002 ...
(Date:9/3/2015)...  Abaxis, Inc. (NasdaqGS: ABAX ), a medical ... the medical, research and veterinary markets, announced today that ... at the CL King 13 th Annual Best ... 11:00 a.m. ET. The conference will be held at ... York City . Abaxis, Inc. is ...
(Date:9/3/2015)... 03, 2015 Research and ... the "Diabetes Care Devices Market In Brazil, Russia, ... Meters, Continuous Glucose Monitors, Testing Strips, Lancets, Insulin Pumps, ... report to their offering. The BRIC diabetes ... USD 1.7 Billion in 2015 and is poised to ...
Breaking Medicine Technology:Investigation Report on China's Trastuzumab (Genentech) Market, 2010-2019 2The BRIC Diabetes Care Devices Market is Estimated to Grow at a CAGR of 6.3% from 2015 to 2020, to Reach USD 2.3 Billion by 2020 2The BRIC Diabetes Care Devices Market is Estimated to Grow at a CAGR of 6.3% from 2015 to 2020, to Reach USD 2.3 Billion by 2020 3
... Club (FC) Barcelona, FC Barcelona Foundation, and ... three-year partnership today to energize the global fight to ... life-saving vaccines.  Bill Gates, co-chair of the Bill & ... Rosell and Manager Josep Guardiola, announced the partnership at ...
... China, July 28, 2011 /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: ... domestic developer, manufacturer and marketer of orthopedic implants in China, ... 2011 financial results on August 16, 2011, before the market ... 8:00 a.m. ET on August 16, 2011 to discuss second ...
Cached Medicine Technology:Futbol Club Barcelona and the Bill & Melinda Gates Foundation Team Up to End Polio and Give Every Child an Equal Shot at Life 2Futbol Club Barcelona and the Bill & Melinda Gates Foundation Team Up to End Polio and Give Every Child an Equal Shot at Life 3China Kanghui Holdings to Report Second Quarter 2011 Financial Results on August 16, 2011 2
(Date:9/3/2015)... ... September 03, 2015 , ... While bariatric surgeon Michael Feiz, M.D., F.A.C.S. notes ... for a bariatric procedure, some patients have been recently asking further questions relating to ... for many types of surgery that should be followed in the days prior to ...
(Date:9/3/2015)... Viejo, CA (PRWEB) , ... September 03, 2015 , ... ... Pro X. Users can choose from wipes and framing transitions in 30 different ... is made exclusively for Final Cut Pro X. , TransPack Toon features 90 cartoon ...
(Date:9/3/2015)... ... September 03, 2015 , ... William Mattar Law Offices is known ... this does not stop at any certain demographic or segment of the population. ... thirty-, fifteen- and ten-second TV commercials. , The closed captioning will allow people with ...
(Date:9/3/2015)... ... 03, 2015 , ... E-Volve Health, an Elliot Health System ... organization, to provide electronic medical record (EMR) consulting services to Amerinet clients running ... negotiated pricing on E-Volve Health’s Epic EMR consulting, custom training and support services. ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... MN, and Indiana University, Indianapolis, have chosen Center for Hospice Care (CHC) ... these institutions will train at CHC as part of fulfilling their requirements for ...
Breaking Medicine News(10 mins):Health News:Dr. Feiz and Associates Answer August's ‘Patient Submitted Question of the Month’: “How Can I Prepare for Weight Loss Surgery” 2Health News:Pixel Film Studios Releases TransPack Toon, a New FCPX Transition 2Health News:Law Firm Focused on “Helping People” Continues to Expand on Vision 2Health News:E-Volve Health to Offer EMR Consulting Solutions to Amerinet Members 2Health News:Physicians from Mayo Clinic and Indiana University to Complete Hospice & Palliative Medicine Training at Center for Hospice Care 2
... ... ... ... ...
... COLUMBIA, Mo. Issues of race and gender are important ... curve in consideration of a subject that affects individuals internationally ... people. The American Sociological Association added the sociology of human ... the issue of human rights for more than 10 years. ...
... ... ... ... ...
... ... ... ... ...
... protheses do not last more than 10-15 years. After this ... change prothesis. It is usually problematic as, in general, it ... based in the Basque city of Donostia-San Sebastin, has just ... first step to solving this problem. According to Ms Garmendia, ...
... ... Side Benefit... Weight Loss. However, One-Ingredient Products May Not Work. , ... Houston, TX – February 23, 2010 – ... hungry and cannot control their dietary urges, such as carbohydrate cravings. Could we lose ...
Cached Medicine News:Health News:Op-Ed: National Forum Calls for Collective Will and More Funding to Fight Hypertension 2Health News:Op-Ed: National Forum Calls for Collective Will and More Funding to Fight Hypertension 3Health News:Op-Ed: National Forum Calls for Collective Will and More Funding to Fight Hypertension 4Health News:Op-Ed: National Forum Calls for Collective Will and More Funding to Fight Hypertension 5Health News:Op-Ed: National Forum Calls for Collective Will and More Funding to Fight Hypertension 6Health News:Sociologist expands US conversation on human rights 2Health News:Diabetics Twice as Likely to Have Hearing Loss; Massachusetts HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 2Health News:Diabetics Twice as Likely to Have Hearing Loss; Massachusetts HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 3Health News:Diabetics Twice as Likely to Have Hearing Loss; Massachusetts HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 4Health News:Diabetics Twice as Likely to Have Hearing Loss; Massachusetts HearUSA Centers to Offer Free Hearing Screening and Diabetes Video in March 5Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 2Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 3Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 4Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 5Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 6Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 7Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 8Health News:Elsevier's new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content 9Health News:Material tested that could guarantee body protheses for more than 150 years 2Health News:Sleep More, Lose Weight – Sleeplessness Linked to Obesity 2Health News:Sleep More, Lose Weight – Sleeplessness Linked to Obesity 3Health News:Sleep More, Lose Weight – Sleeplessness Linked to Obesity 4
... Safety Clear Plus™ Uncuffed Endotracheal Tube w. FlexiSlip™ ... Single use. A quality Rusch endotracheal tube with ... saving you time and storage space. The stylet ... withdrawal. It is designed with a soft distal ...
... with stylet inside. Sterile, Latex Free, ... endotracheal tube with a preloaded Slick® ... you time and storage space. The ... identification and has a stopper to ...
Ruschelit® PVC. Magill tip-nasoral. Black positioning ring. High volume/low pressure cuff. X-ray opaque line. Graduated. Single use....
... tube with Murphy eye. Laser resistant foam surrounds ... cuffs (One inside other) 40cm (16") long, Single ... maximum access and optimum visibility within the operating ... has a special laser-guard of approx. 17cm in ...
Medicine Products: